ProfileGDS4718 / 209545_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 78% 75% 79% 73% 66% 88% 87% 74% 69% 71% 78% 66% 89% 90% 89% 83% 70% 89% 87% 85% 75% 73% 71% 67% 75% 84% 69% 83% 68% 87% 83% 80% 74% 77% 90% 85% 89% 75% 74% 80% 76% 87% 82% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.5860578
GSM549102patient 115, normal, homogenized [OPG study]7.3081575
GSM549104patient 119, normal, homogenized [OPG study]7.8141879
GSM549108patient 138, normal, homogenized [OPG study]7.0706973
GSM549119patient 077, normal, homogenized [OPG study]6.5676866
GSM549133patient 032, cancer, homogenized [OPG study]9.0352788
GSM549139patient 042, cancer, homogenized [OPG study]8.8099287
GSM549099patient 107, normal, homogenized [OPG study]7.1925374
GSM549109patient 139, normal, homogenized [OPG study]6.7967569
GSM549110patient 046, normal, homogenized [OPG study]6.888671
GSM549114patient 063, normal, homogenized [OPG study]7.6771478
GSM549122patient 082, normal, homogenized [OPG study]6.5892466
GSM549134patient 033, cancer, homogenized [OPG study]8.9793989
GSM549136patient 036, cancer, homogenized [OPG study]9.2042290
GSM549140patient 044, cancer, homogenized [OPG study]9.1538489
GSM549111patient 047, normal, homogenized [OPG study]8.2724683
GSM549113patient 057, normal, homogenized [OPG study]6.8527670
GSM549132patient 031, cancer, homogenized [OPG study]9.0375789
GSM549137patient 038, cancer, homogenized [OPG study]8.6583287
GSM549142patient 047, cancer, homogenized [OPG study]8.0932185
GSM549100patient 110, normal, homogenized [OPG study]7.3043975
GSM549107patient 135, normal, homogenized [OPG study]7.1562373
GSM549115patient 068, normal, homogenized [OPG study]6.9528671
GSM549116patient 072, normal, homogenized [OPG study]6.6734667
GSM549120patient 078, normal, homogenized [OPG study]7.2793575
GSM549131patient 030, cancer, homogenized [OPG study]8.4369784
GSM549118patient 074, normal, homogenized [OPG study]6.7619669
GSM549129patient 027, cancer, homogenized [OPG study]8.2397583
GSM549123patient 088, normal, homogenized [OPG study]6.6970968
GSM549124patient 006, cancer, homogenized [OPG study]8.5495687
GSM549126patient 015, cancer, homogenized [OPG study]8.2301683
GSM549128patient 025, cancer, homogenized [OPG study]7.9846980
GSM549103patient 117, normal, homogenized [OPG study]7.1601374
GSM549117patient 073, normal, homogenized [OPG study]7.5381177
GSM549138patient 041, cancer, homogenized [OPG study]9.1973990
GSM549141patient 045, cancer, homogenized [OPG study]8.5455185
GSM549130patient 028, cancer, homogenized [OPG study]8.8689289
GSM549101patient 111, normal, homogenized [OPG study]7.3317275
GSM549105patient 128, normal, homogenized [OPG study]7.2119674
GSM549106patient 134, normal, homogenized [OPG study]8.067280
GSM549112patient 048, normal, homogenized [OPG study]7.4143676
GSM549125patient 011, cancer, homogenized [OPG study]8.6262587
GSM549127patient 024, cancer, homogenized [OPG study]8.086682
GSM549135patient 035, cancer, homogenized [OPG study]9.4083191